INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2020

Mar 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2020-03-21

Reporting Person: Miller Ann Calby (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-21	Common Stock	M	4274	—	Acquired	4274	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-21	Restricted Stock Unit	$	M	4274	Disposed		Common Stock (4274.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on March 21, 2020; 4,274 shares will vest on March 21, 2021; 4,273 shares will vest on March 21, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.